{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:01:14Z","timestamp":1776340874354,"version":"3.51.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972840"],"award-info":[{"award-number":["81972840"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019933","name":"Shanxi Collaborative Innovation Center of High Value-added Utilization of Coal-related Wastes","doi-asserted-by":"publisher","award":["BD2023005"],"award-info":[{"award-number":["BD2023005"]}],"id":[{"id":"10.13039\/501100019933","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08048-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:36:20Z","timestamp":1775046980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The MAFG-AS1\/G6PD axis reduces platinum sensitivity in colorectal cancer through pentose phosphate pathway activation"],"prefix":"10.1186","volume":"24","author":[{"given":"Jia Hui","family":"Kou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Meng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Man","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-6817","authenticated-orcid":false,"given":"Su Tang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"8048_CR1","doi-asserted-by":"publisher","unstructured":"Zhao XH, Han MM, Yan QQ, Yue YM, Ye K, Zhang YY, Teng L, Xu L, Shi XJ, La T, et al. DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer. Cell Death Dis. 2025;16. https:\/\/doi.org\/10.1038\/s41419-025-07334-4.","DOI":"10.1038\/s41419-025-07334-4"},{"key":"8048_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"key":"8048_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736.","journal-title":"Gut"},{"key":"8048_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"8048_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44:222\u201336. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003.","journal-title":"Trends Pharmacol Sci"},{"key":"8048_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-023-00432-7","volume":"9","author":"MCW Spaander","year":"2023","unstructured":"Spaander MCW, Zauber AG, Syngal S, Blaser MJ, Sung JJ, You YN, Kuipers EJ. Young-onset colorectal cancer. Nat Rev Dis Primers. 2023;9:21. https:\/\/doi.org\/10.1038\/s41572-023-00432-7.","journal-title":"Nat Rev Dis Primers"},{"key":"8048_CR7","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/s1470-2045(21)00588-x","volume":"23","author":"C Eng","year":"2022","unstructured":"Eng C, J\u00e1come AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, Bailey C, Lieu CH. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 2022;23:e116\u201328. https:\/\/doi.org\/10.1016\/s1470-2045(21)00588-x.","journal-title":"Lancet Oncol"},{"key":"8048_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","volume":"10","author":"B Li","year":"2025","unstructured":"Li B, Ming H, Qin S, Nice EC, Dong J, Du Z, Huang C. Redox regulation: mechanisms, biology and therapeutic targets in diseases. Signal Transduct Target Ther. 2025;10:72. https:\/\/doi.org\/10.1038\/s41392-024-02095-6.","journal-title":"Signal Transduct Target Ther"},{"key":"8048_CR9","doi-asserted-by":"publisher","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368. https:\/\/doi.org\/10.1126\/science.aaw5473.","DOI":"10.1126\/science.aaw5473"},{"issue":"4","key":"8048_CR10","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1002\/mco2.218","volume":"2023","author":"S Nong","year":"2020","unstructured":"Nong S, Han X, Xiang Y, Qian Y, Wei Y, Zhang T, Tian K, Shen K, Yang J, Ma X. Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm. 2020;2023(4):e218. https:\/\/doi.org\/10.1002\/mco2.218.","journal-title":"MedComm"},{"key":"8048_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discov. 2024;23:583\u2013606. https:\/\/doi.org\/10.1038\/s41573-024-00979-4.","journal-title":"Nat Rev Drug Discov"},{"key":"8048_CR12","doi-asserted-by":"publisher","unstructured":"Chen YS, Tian HX, Rong DC, Wang L, Chen S, Zeng J, Xu H, Mei J, Wang LY, Liou YL, et al. ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions. Mol Biomed. 2025;6. https:\/\/doi.org\/10.1186\/s43556-025-00338-8.","DOI":"10.1186\/s43556-025-00338-8"},{"key":"8048_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1152\/physrev.00044.2023","volume":"105","author":"J Sastre","year":"2025","unstructured":"Sastre J, P\u00e9rez S, Sabater L, Rius-P\u00e9rez S. Redox signaling in the pancreas in health and disease. Physiol Rev. 2025;105:593\u2013650. https:\/\/doi.org\/10.1152\/physrev.00044.2023.","journal-title":"Physiol Rev"},{"key":"8048_CR14","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nat Metab. 2023;5:1275\u201389. https:\/\/doi.org\/10.1038\/s42255-023-00863-2.","journal-title":"Nat Metab"},{"key":"8048_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","volume":"5","author":"P Jiang","year":"2014","unstructured":"Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell. 2014;5:592\u2013602. https:\/\/doi.org\/10.1007\/s13238-014-0082-8.","journal-title":"Protein Cell"},{"key":"8048_CR16","doi-asserted-by":"publisher","first-page":"eabo0404","DOI":"10.1126\/sciadv.abo0404","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu Y, Lu W, Li J, Yu S, Brown EJ, Stanger BZ, Rabinowitz JD, Yang X. G6PD-mediated increase in de novo NADP(+) biosynthesis promotes antioxidant defense and tumor metastasis. Sci Adv. 2022;8:eabo0404. https:\/\/doi.org\/10.1126\/sciadv.abo0404.","journal-title":"Sci Adv"},{"key":"8048_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41589-020-0533-x","volume":"16","author":"JM Ghergurovich","year":"2020","unstructured":"Ghergurovich JM, Garc\u00eda-Ca\u00f1averas JC, Wang J, Schmidt E, Zhang Z, TeSlaa T, Patel H, Chen L, Britt EC, Piqueras-Nebot M, et al. A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nat Chem Biol. 2020;16:731\u20139. https:\/\/doi.org\/10.1038\/s41589-020-0533-x.","journal-title":"Nat Chem Biol"},{"key":"8048_CR18","doi-asserted-by":"publisher","first-page":"217297","DOI":"10.1016\/j.canlet.2024.217297","volume":"605","author":"R Nadhan","year":"2024","unstructured":"Nadhan R, Isidoro C, Song YS, Dhanasekaran DN. LncRNAs and the cancer epigenome: Mechanisms and therapeutic potential. Cancer Lett. 2024;605:217297. https:\/\/doi.org\/10.1016\/j.canlet.2024.217297.","journal-title":"Cancer Lett"},{"key":"8048_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2020.11.048","volume":"501","author":"A Nandwani","year":"2021","unstructured":"Nandwani A, Rathore S, Datta M. LncRNAs in cancer: Regulatory and therapeutic implications. Cancer Lett. 2021;501:162\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.048.","journal-title":"Cancer Lett"},{"key":"8048_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.7150\/ijbs.40769","volume":"16","author":"W Lin","year":"2020","unstructured":"Lin W, Zhou Q, Wang CQ, Zhu L, Bi C, Zhang S, Wang X, Jin H. LncRNAs regulate metabolism in cancer. Int J Biol Sci. 2020;16:1194\u2013206. https:\/\/doi.org\/10.7150\/ijbs.40769.","journal-title":"Int J Biol Sci"},{"key":"8048_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-021-01488-3","volume":"21","author":"J Zuo","year":"2022","unstructured":"Zuo J, Zhang Z, Li M, Yang Y, Zheng B, Wang P, Huang C, Zhou S. The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role. Mol Cancer. 2022;21:30. https:\/\/doi.org\/10.1186\/s12943-021-01488-3.","journal-title":"Mol Cancer"},{"key":"8048_CR22","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xu L, Ren Z, Liu X, Song J, Zhang P, Zhang C, Gong S, Wu N, Zhang X, et al. LINC01615 maintains cell survival in adaptation to nutrient starvation through the pentose phosphate pathway and modulates chemosensitivity in colorectal cancer. Cell Mol Life Sci. 2022;80. https:\/\/doi.org\/10.1007\/s00018-022-04675-7.","DOI":"10.1007\/s00018-022-04675-7"},{"key":"8048_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.02.035","author":"Y Hu","year":"2025","unstructured":"Hu Y, Chen M, Sun S, Zhang C, Xin Z, Sun X, Wang K, Jin K, Du X, Xing B, et al. Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.02.035.","journal-title":"J Adv Res"},{"key":"8048_CR24","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1038\/s41388-019-0935-y","volume":"38","author":"L Moreno Leon","year":"2019","unstructured":"Moreno Leon L, Gautier M, Allan R, Ili\u00e9 M, Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, et al. The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress. Oncogene. 2019;38:7146\u201365. https:\/\/doi.org\/10.1038\/s41388-019-0935-y.","journal-title":"Oncogene"},{"key":"8048_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336. https:\/\/doi.org\/10.1038\/s41571-021-00549-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"8048_CR26","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82:2252\u201366. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.027.","journal-title":"Mol Cell"},{"key":"8048_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41588-024-01677-y","volume":"56","author":"MYC activates transcriptional enhancers to drive cancer progression","year":"2024","unstructured":"MYC activates transcriptional enhancers to drive cancer progression. Nat Genet. 2024;56:567\u20138. https:\/\/doi.org\/10.1038\/s41588-024-01677-y.","journal-title":"Nat Genet"},{"key":"8048_CR28","doi-asserted-by":"publisher","unstructured":"Ding Z, Hagan M, Yan F, Schroer NWY, Polmear J, Good-Jacobson KL, Dvorscek AR, Pitt C, O\u2019Donnell K, Nutt SL, et al. Ki67 deficiency impedes chromatin accessibility and BCR gene rearrangement. J Exp Med. 2024;221. https:\/\/doi.org\/10.1084\/jem.20232160.","DOI":"10.1084\/jem.20232160"},{"key":"8048_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","volume":"93","author":"JM Paggi","year":"2024","unstructured":"Paggi JM, Pandit A, Dror RO. The Art and Science of Molecular Docking. Annu Rev Biochem. 2024;93:389\u2013410. https:\/\/doi.org\/10.1146\/annurev-biochem-030222-120000.","journal-title":"Annu Rev Biochem"},{"key":"8048_CR30","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1038\/s41467-020-18735-8","volume":"11","author":"YC Feng","year":"2020","unstructured":"Feng YC, Liu XY, Teng L, Ji Q, Wu Y, Li JM, Gao W, Zhang YY, La T, Tabatabaee H, et al. c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis. Nat Commun. 2020;11:4980. https:\/\/doi.org\/10.1038\/s41467-020-18735-8.","journal-title":"Nat Commun"},{"key":"8048_CR31","doi-asserted-by":"publisher","first-page":"e2820","DOI":"10.1038\/cddis.2017.85","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhang X, Li Y, Shao Y, Xiao J, Zhu G, Li F. PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth. Cell Death Dis. 2017;8:e2820. https:\/\/doi.org\/10.1038\/cddis.2017.85.","journal-title":"Cell Death Dis"},{"key":"8048_CR32","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.drup.2024.101152","volume":"77","author":"S Luo","year":"2024","unstructured":"Luo S, Yue M, Wang D, Lu Y, Wu Q, Jiang J. Breaking the barrier: Epigenetic strategies to combat platinum resistance in colorectal cancer. Drug Resist Updat. 2024;77:101152. https:\/\/doi.org\/10.1016\/j.drup.2024.101152.","journal-title":"Drug Resist Updat"},{"key":"8048_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24:679\u201386. https:\/\/doi.org\/10.1038\/leu.2010.6.","journal-title":"Leukemia"},{"key":"8048_CR34","doi-asserted-by":"publisher","first-page":"189175","DOI":"10.1016\/j.bbcan.2024.189175","volume":"1879","author":"A Chen","year":"2024","unstructured":"Chen A, Huang H, Fang S, Hang Q. ROS: A booster for chronic inflammation and tumor metastasis. Biochim Biophys Acta Rev Cancer. 2024;1879:189175. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189175.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8048_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7150\/thno.50028","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Zhao X, Nie W, Yang Y, Wu C, Liu W, Zhang K, Zhang Z, Shi J. Tumor cell-activated Sustainable ROS Generator with homogeneous intratumoral distribution property for improved anti-tumor therapy. Theranostics. 2021;11:379\u201396. https:\/\/doi.org\/10.7150\/thno.50028.","journal-title":"Theranostics"},{"key":"8048_CR36","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","volume":"66","author":"L Xiang","year":"2021","unstructured":"Xiang L, Zeng Q, Liu J, Xiao M, He D, Zhang Q, Xie D, Deng M, Zhu Y, Liu Y, et al. MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis. Sci Bull (Beijing). 2021;66:1773\u201388. https:\/\/doi.org\/10.1016\/j.scib.2021.01.027.","journal-title":"Sci Bull (Beijing)"},{"key":"8048_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41420-022-01043-z","volume":"8","author":"S Di","year":"2022","unstructured":"Di S, Bai R, Lu D, Chen C, Ma T, Zou Z, Zhang Z. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway. Cell Death Discov. 2022;8:249. https:\/\/doi.org\/10.1038\/s41420-022-01043-z.","journal-title":"Cell Death Discov"},{"key":"8048_CR38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/15384101.2020.1728017","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, Wu R, Xing Y. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer. Cell Cycle. 2020;19:601\u20139. https:\/\/doi.org\/10.1080\/15384101.2020.1728017.","journal-title":"Cell Cycle"},{"key":"8048_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12935-020-01669-y","volume":"20","author":"L Ye","year":"2020","unstructured":"Ye L, Feng W, Weng H, Yuan C, Liu J, Wang Z. MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX. Cancer Cell Int. 2020;20:591. https:\/\/doi.org\/10.1186\/s12935-020-01669-y.","journal-title":"Cancer Cell Int"},{"key":"8048_CR40","doi-asserted-by":"publisher","first-page":"114756","DOI":"10.1016\/j.biopha.2023.114756","volume":"163","author":"Z Huang","year":"2023","unstructured":"Huang Z, Zhang M, Li J, Lou C. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Biomed Pharmacother. 2023;163:114756. https:\/\/doi.org\/10.1016\/j.biopha.2023.114756.","journal-title":"Biomed Pharmacother"},{"key":"8048_CR41","doi-asserted-by":"publisher","first-page":"688603","DOI":"10.3389\/fcell.2021.688603","volume":"9","author":"T Chen","year":"2021","unstructured":"Chen T, Huang B, Pan Y. Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196\/STRN4 in Drug-Resistant Cells of Liver Cancer. Front Cell Dev Biol. 2021;9:688603. https:\/\/doi.org\/10.3389\/fcell.2021.688603.","journal-title":"Front Cell Dev Biol"},{"key":"8048_CR42","doi-asserted-by":"publisher","unstructured":"Golara A, Koz\u0142owski M, Cymbaluk-P\u0142oska A. The Role of Long Non-Coding RNAs in Ovarian Cancer Cells. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25189922.","DOI":"10.3390\/ijms25189922"},{"key":"8048_CR43","doi-asserted-by":"publisher","first-page":"e21529","DOI":"10.1096\/fj.202002374R","volume":"35","author":"F Zhang","year":"2021","unstructured":"Zhang F, Li Y, Gan L, Tong X, Qi D, Wang Q, Ye X. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. Faseb j. 2021;35:e21529. https:\/\/doi.org\/10.1096\/fj.202002374R.","journal-title":"Faseb j"},{"key":"8048_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s43018-020-0086-7","volume":"1","author":"M Li","year":"2020","unstructured":"Li M, He X, Guo W, Yu H, Zhang S, Wang N, Liu G, Sa R, Shen X, Jiang Y, et al. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways. Nat Cancer. 2020;1:735\u201347. https:\/\/doi.org\/10.1038\/s43018-020-0086-7.","journal-title":"Nat Cancer"},{"key":"8048_CR45","doi-asserted-by":"publisher","first-page":"1183474","DOI":"10.3389\/fonc.2023.1183474","volume":"13","author":"T Zeng","year":"2023","unstructured":"Zeng T, Li B, Shu X, Pang J, Wang H, Cai X, Liao Y, Xiao X, Chong Y, Gong J, et al. Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers. Front Oncol. 2023;13:1183474. https:\/\/doi.org\/10.3389\/fonc.2023.1183474.","journal-title":"Front Oncol"},{"key":"8048_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12935-020-01576-2","volume":"20","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Yang Z, Ni Y, Bai H, Han Q, Yi Z, Yi X, Agbana YL, Kuang Y, Zhu Y. NF-\u03baB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC. Cancer Cell Int. 2020;20:483. https:\/\/doi.org\/10.1186\/s12935-020-01576-2.","journal-title":"Cancer Cell Int"},{"key":"8048_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bj.2020.08.001","volume":"44","author":"HC Yang","year":"2021","unstructured":"Yang HC, Stern A, Chiu DT. G6PD: A hub for metabolic reprogramming and redox signaling in cancer. Biomed J. 2021;44:285\u201392. https:\/\/doi.org\/10.1016\/j.bj.2020.08.001.","journal-title":"Biomed J"},{"key":"8048_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbrc.2018.02.211","volume":"498","author":"X Yang","year":"2018","unstructured":"Yang X, Ye H, He M, Zhou X, Sun N, Guo W, Lin X, Huang H, Lin Y, Yao R, et al. LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma. Biochem Biophys Res Commun. 2018;498:207\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.211.","journal-title":"Biochem Biophys Res Commun"},{"key":"8048_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13073-025-01488-8","volume":"17","author":"K Nesic","year":"2025","unstructured":"Nesic K, Parker P, Swisher EM, Krais JJ. DNA repair and the contribution to chemotherapy resistance. Genome Med. 2025;17:62. https:\/\/doi.org\/10.1186\/s13073-025-01488-8.","journal-title":"Genome Med"},{"key":"8048_CR50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5c00041","author":"JX Kee","year":"2025","unstructured":"Kee JX, Yau JNN, Kumar Muthuramalingam RP, Wang X, Chng WH, Lopez-Sanchez A, Tay KKW, Deng LW, Gibson D, Bertrand HC, et al. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. Chem Rev. 2025. https:\/\/doi.org\/10.1021\/acs.chemrev.5c00041.","journal-title":"Chem Rev"},{"key":"8048_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39:347\u201354. https:\/\/doi.org\/10.1016\/j.tibs.2014.06.005.","journal-title":"Trends Biochem Sci"},{"key":"8048_CR52","doi-asserted-by":"publisher","first-page":"eadu2906","DOI":"10.1126\/sciadv.adu2906","volume":"11","author":"GR McGivney","year":"2025","unstructured":"McGivney GR, Brockman QR, Borcherding N, Scherer A, Rauckhorst AJ, Gutierrez WR, Solst SR, Heer CD, Warrier A, Floyd W, et al. Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. Sci Adv. 2025;11:eadu2906. https:\/\/doi.org\/10.1126\/sciadv.adu2906.","journal-title":"Sci Adv"},{"key":"8048_CR53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ncb2172","volume":"13","author":"P Jiang","year":"2011","unstructured":"Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol. 2011;13:310\u20136. https:\/\/doi.org\/10.1038\/ncb2172.","journal-title":"Nat Cell Biol"},{"key":"8048_CR54","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351. https:\/\/doi.org\/10.1056\/NEJMoa032709.","journal-title":"N Engl J Med"},{"key":"8048_CR55","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jama.2021.2454","volume":"325","author":"JA Meyerhardt","year":"2021","unstructured":"Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, et al. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB\/SWOG 80702 (Alliance) Randomized Clinical Trial. JAMA. 2021;325:1277\u201386. https:\/\/doi.org\/10.1001\/jama.2021.2454.","journal-title":"JAMA"},{"key":"8048_CR56","doi-asserted-by":"publisher","first-page":"117274","DOI":"10.1016\/j.bcp.2025.117274","volume":"242","author":"AS Reis","year":"2025","unstructured":"Reis AS, Martins CC, da Fonseca CAR, Costa GP, Alves D, Balbinot FP, Domingues WB, Martins AWS, Campos VF, Flores EMM, et al. Aging as a critical factor in chronic oxaliplatin-induced neuropathy: Protective effects of 7-chloro-4-(phenylselanyl) quinoline through modulation of NF-\u03baB and Drp1 expression, and platinum distribution. Biochem Pharmacol. 2025;242:117274. https:\/\/doi.org\/10.1016\/j.bcp.2025.117274.","journal-title":"Biochem Pharmacol"},{"key":"8048_CR57","doi-asserted-by":"publisher","unstructured":"Wong SQR, Das M, Tenzin K, Shirgaonkar N, Chua H, Chee LX, Sae Yeoh A, Murugiah AA, Chua WY, Theardy MS, et al. Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype. Cell Death Dis. 2025;16. https:\/\/doi.org\/10.1038\/s41419-025-07855-y.","DOI":"10.1038\/s41419-025-07855-y"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08048-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08048-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08048-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:16:45Z","timestamp":1776338205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08048-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8048"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08048-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee of Shanxi Cancer Hospital (Approval number: 2019LL009) and conducted in accordance with the principles of the Declaration of Helsinki. All animal experiments were performed following relevant guidelines and regulations and were approved by t Animal Laboratory Center of Zhengzhou University (ZZU-LAC2025090915; Zhengzhou, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to being listed as authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors consent to being listed as authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"517"}}